Correlation between Endothelial Dysfunction, Rho-associated Protein Kinase Activity, C-reactive Protein and Obstructive Sleep Apnoea Syndrome in Male Patients

By Zhang L   Zhuang J-H   Peng H   Huang J   Huang L-Q   Zhao Z-X  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2183-2190

Field House Publishing

Access to resources Recommend Favorite

Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model

By Takahara A.   Sugiyama A.   Satoh Y.   Yoneyama M.   Hashimoto K.  

European Journal of Pharmacology, Vol. 460, Iss. 1, 2003-01 ,pp. : 51-57

Elsevier

Access to resources Recommend Favorite

Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy

By Hanefeld Christoph   Bulut-Streich Nadine   Bulut Daniel   Graf Claudia   Mügge Andreas   Spiecker Martin  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 153-155

Springer Publishing Company

Access to resources Recommend Favorite

Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia: The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study

By Smilde T.J.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 67-79

Adis International

Access to resources Recommend Favorite

Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3108-3115

Bentham Science Publishers

Access to resources Recommend Favorite